Praxis Precision Medicines, Inc. (PRAX) Q1 2025 Earnings
PRAX·Reported May 2, 2025·Before market open
Diluted EPS came in at $-3.29 (-15.8% YoY), missed the $-3.20 consensus by $0.09.
Diluted EPS
$-3.29missed by $0.09
Consensus: $-3.20
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Praxis Precision Medicines, Inc.'s Q1 2025 earnings report.
Praxis Precision Medicines, Inc. (PRAX) reported Q1 2025 earnings on May 2, 2025 before market open.
Praxis Precision Medicines, Inc. reported diluted EPS of $-3.29 for Q1 2025.
EPS missed the consensus estimate of $-3.20 by $0.09.
Compared to the same quarter a year prior, diluted EPS declined 15.8% from $-2.84.
You can read the 10-Q periodic report (0001689548-25-000058) directly on SEC EDGAR. The filing index links above go to sec.gov.